Michelle Robertson - Jan 11, 2022 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Role
Chief Financial Officer
Signature
/s/ Michelle Robertson
Stock symbol
EDIT
Transactions as of
Jan 11, 2022
Transactions value $
-$44,821
Form type
4
Date filed
1/13/2022, 03:17 PM
Previous filing
Dec 23, 2021
Next filing
Feb 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EDIT Common Stock Sale -$44.8K -1.74K -5.25% $25.70 31.5K Jan 11, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on December 30, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on January 9, 2022. The sale does not represent a discretionary trade by the Reporting Person.